Skip to main content
Fig. 5 | BMC Ophthalmology

Fig. 5

From: Risk factors leading to trabeculectomy surgery of glaucoma patient using Japanese nationwide administrative claims data: a retrospective non-interventional cohort study

Fig. 5

Treatment patterns of prescribed topical glaucoma drugs (eye drops) at the index admission in the cataract surgery (a) and non-cataract surgery (b) combined with glaucoma surgery cohorts. AA, α2-agonist; AB. α1-blocker; ABB, αβ-blocker; BB, β-blocker; Bim, bimatoprost; CAI, carbonic anhydrase inhibitor; Lat, latanoprost; PG, prostaglandin analog; ROCKI, Rho-associated protein kinase inhibitor; Sym, sympathomimetics; Taf, tafluprost; Tra, travoprost

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us